The safety of fluoxetine during pregnancy and lactation.
Nulman
I
I
Department of Pediatrics, Hospital for Sick Children, Toronto, Ontario, Canada.
Koren
G
G
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000818:Animals; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000633:toxicity; D001942:Breast Feeding; D005260:Female; D005473:Fluoxetine / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000633:toxicity; D006801:Humans; D007231:Infant, Newborn; D007774:Lactation; D051379:Mice; D011247:Pregnancy; D051381:Rats; D012449:Safety; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000633:toxicity; D013723:Teratogens / Q000493:pharmacokinetics / Q000633:toxicity*
D018687:Antidepressive Agents, Second-Generation; D005473:Fluoxetine; D017367:Selective Serotonin Reuptake Inhibitors; D013723:Teratogens